HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CVXGA1 COVID-19 vaccine

parainfluenza virus 5 (PIV5) expressing the SARS-CoV-2 spike protein containing vaccine

Also Known As:

CVXGA1; CVXGA1 vaccine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Viral Vaccines: 462
      - COVID-19 Vaccines: 7607
        CVXGA1 COVID-19 vaccine: 1

Experts

1.	An, Dong: 1 article (07/2021)
2.	Beavis, Ashley C: 1 article (07/2021)
3.	Briggs, Kelsey: 1 article (07/2021)
4.	Brindley, Melinda: 1 article (07/2021)
5.	Diaz, Maria Cristina Huertas: 1 article (07/2021)
6.	Griffin, Emily F: 1 article (07/2021)
7.	He, Biao: 1 article (07/2021)
8.	Huang, Jiachen: 1 article (07/2021)
9.	Johnson, Scott K: 1 article (07/2021)
10.	Jones, Cheryl A: 1 article (07/2021)

Related Diseases

1.	Virus Diseases (Viral Diseases) 07/01/2021 - "CVXGA1 immunization also prevented virus infection of ferrets and blocked contact transmission. "
2.	Infections 07/01/2021 - "Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing the SARS-CoV-2 S protein (CVXGA1), and then demonstrated that a single-dose intranasal immunization with CVXGA1 protects against lethal infection of K18-hACE2 mice, a severe disease model. "

Related Drugs and Biologics

1.	Vaccines
2.	SARS-CoV-2 spike protein